- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapse After Use of Lenalidomide and Bortezomib in Norway
Total 5 results
-
Oslo University HospitalCompletedIncidence of Symptomatic Lymphocele After Kidney Transplantation | Prevalence of Perirenal Fluid Collections at One, Five and Ten WeeksNorway
-
University Hospital, AkershusUniversity of OsloRecruitingHarmful Use of HypnoticNorway
-
Norwegian Institute of Public HealthOslo University Hospital; Norwegian Centre for Transport ResearchCompletedInjuries | Work Disability | Employment Status | Use of Prescribed DrugsNorway
-
Ostfold Hospital TrustThe Dam Foundation; Sykehuset Innlandet HF; Norwegian Health AssociationCompletedDepression | Quality of Life | Anxiety | Cognitive Symptom | Drug Use | Physical Health | Activity of Daily Living | Neuropsychiatric SyndromeNorway
-
SanofiTerminatedMultiple Sclerosis RelapseSpain, Germany, Sweden, Canada, Austria, Korea, Republic of, Russian Federation, Greece, Hungary, Italy, Belgium, Slovakia, Tunisia, France, Australia, United States, Argentina, Brazil, Chile, Colombia, Denmark, Estonia, Finland, Lith... and more